Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.
Identifieur interne : 003759 ( PubMed/Curation ); précédent : 003758; suivant : 003760Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.
Auteurs : Kim Vietz Andreassen [Danemark] ; Sara Toftegaard Hjuler [Danemark] ; Sebastian G. Furness [Australie] ; Patrick M. Sexton [Australie] ; Arthur Christopoulos [Australie] ; Olivier Nosjean [France] ; Morten Asser Karsdal [Danemark] ; Kim Henriksen [Danemark]Source :
- PloS one [ 1932-6203 ] ; 2014.
Descripteurs français
- KwdFr :
- AMP cyclique (métabolisme), Animaux, Arrestines (génétique), Arrestines (métabolisme), Calcitonine (génétique), Calcitonine (métabolisme), Facteurs temps, Humains, Ligands, Lignée cellulaire, Récepteurs à la calcitonine (génétique), Récepteurs à la calcitonine (métabolisme), Régulation de l'expression des gènes, Saumon, Spécificité d'espèce, Transduction du signal (génétique), Transgènes, Transport de protéines, bêta-Arrestines.
- MESH :
- génétique : Arrestines, Calcitonine, Récepteurs à la calcitonine, Transduction du signal.
- métabolisme : AMP cyclique, Arrestines, Calcitonine, Récepteurs à la calcitonine.
- Animaux, Facteurs temps, Humains, Ligands, Lignée cellulaire, Régulation de l'expression des gènes, Saumon, Spécificité d'espèce, Transgènes, Transport de protéines, bêta-Arrestines.
English descriptors
- KwdEn :
- Animals, Arrestins (genetics), Arrestins (metabolism), Calcitonin (genetics), Calcitonin (metabolism), Cell Line, Cyclic AMP (metabolism), Gene Expression Regulation, Humans, Ligands, Protein Transport, Receptors, Calcitonin (genetics), Receptors, Calcitonin (metabolism), Salmon, Signal Transduction (genetics), Species Specificity, Time Factors, Transgenes, beta-Arrestins.
- MESH :
- chemical , genetics : Arrestins, Calcitonin, Receptors, Calcitonin.
- chemical , metabolism : Arrestins, Calcitonin, Cyclic AMP, Receptors, Calcitonin.
- genetics : Signal Transduction.
- Animals, Cell Line, Gene Expression Regulation, Humans, Ligands, Protein Transport, Salmon, Species Specificity, Time Factors, Transgenes, beta-Arrestins.
Abstract
Salmon calcitonin (sCT) and human calcitonin (hCT) are pharmacologically distinct. However, the reason for the differences is unclear. Here we analyze the differences between sCT and hCT on the human calcitonin receptor (CT(a)R) with respect to activation of cAMP signaling, β-arrestin recruitment, ligand binding kinetics and internalization. The study was conducted using mammalian cell lines heterologously expressing the human CT(a) receptor. CT(a)R downstream signaling was investigated with dose response profiles for cAMP production and β-arrestin recruitment for sCT and hCT during short term (<2 hours) and prolonged (up to 72 hours) stimulation. CT(a)R kinetics and internalization was investigated with radio-labeled sCT and hCT ligands on cultured cells and isolated membrane preparations from the same cell line. We found that sCT and hCT are equipotent during short-term stimulations with differences manifesting themselves only during long-term stimulation with sCT inducing a prolonged activation up to 72 hours, while hCT loses activity markedly earlier. The prolonged sCT stimulation of both cAMP accumulation and β-arrestin recruitment was attenuated, but not abrogated by acid wash, suggesting a role for sCT activated internalized receptors. We have demonstrated a novel phenomenon, namely that two distinct CT(a)R downstream signaling activation patterns are activated by two related ligands, thereby highlighting qualitatively different signaling responses in vitro that could have implications for sCT use in vivo.
DOI: 10.1371/journal.pone.0092042
PubMed: 24643196
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003874
Links to Exploration step
pubmed:24643196Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.</title><author><name sortKey="Andreassen, Kim Vietz" sort="Andreassen, Kim Vietz" uniqKey="Andreassen K" first="Kim Vietz" last="Andreassen">Kim Vietz Andreassen</name><affiliation wicri:level="1"><nlm:affiliation>Nordic Bioscience A/S, Herlev, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Nordic Bioscience A/S, Herlev</wicri:regionArea></affiliation></author><author><name sortKey="Hjuler, Sara Toftegaard" sort="Hjuler, Sara Toftegaard" uniqKey="Hjuler S" first="Sara Toftegaard" last="Hjuler">Sara Toftegaard Hjuler</name><affiliation wicri:level="1"><nlm:affiliation>Nordic Bioscience A/S, Herlev, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Nordic Bioscience A/S, Herlev</wicri:regionArea></affiliation></author><author><name sortKey="Furness, Sebastian G" sort="Furness, Sebastian G" uniqKey="Furness S" first="Sebastian G" last="Furness">Sebastian G. Furness</name><affiliation wicri:level="1"><nlm:affiliation>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Sexton, Patrick M" sort="Sexton, Patrick M" uniqKey="Sexton P" first="Patrick M" last="Sexton">Patrick M. Sexton</name><affiliation wicri:level="1"><nlm:affiliation>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Christopoulos, Arthur" sort="Christopoulos, Arthur" uniqKey="Christopoulos A" first="Arthur" last="Christopoulos">Arthur Christopoulos</name><affiliation wicri:level="1"><nlm:affiliation>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Nosjean, Olivier" sort="Nosjean, Olivier" uniqKey="Nosjean O" first="Olivier" last="Nosjean">Olivier Nosjean</name><affiliation wicri:level="1"><nlm:affiliation>Institut de Recherches Servier, Croissy-sur-Seine, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut de Recherches Servier, Croissy-sur-Seine</wicri:regionArea></affiliation></author><author><name sortKey="Karsdal, Morten Asser" sort="Karsdal, Morten Asser" uniqKey="Karsdal M" first="Morten Asser" last="Karsdal">Morten Asser Karsdal</name><affiliation wicri:level="1"><nlm:affiliation>Nordic Bioscience A/S, Herlev, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Nordic Bioscience A/S, Herlev</wicri:regionArea></affiliation></author><author><name sortKey="Henriksen, Kim" sort="Henriksen, Kim" uniqKey="Henriksen K" first="Kim" last="Henriksen">Kim Henriksen</name><affiliation wicri:level="1"><nlm:affiliation>Nordic Bioscience A/S, Herlev, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Nordic Bioscience A/S, Herlev</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24643196</idno><idno type="pmid">24643196</idno><idno type="doi">10.1371/journal.pone.0092042</idno><idno type="wicri:Area/PubMed/Corpus">003874</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003874</idno><idno type="wicri:Area/PubMed/Curation">003759</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003759</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.</title><author><name sortKey="Andreassen, Kim Vietz" sort="Andreassen, Kim Vietz" uniqKey="Andreassen K" first="Kim Vietz" last="Andreassen">Kim Vietz Andreassen</name><affiliation wicri:level="1"><nlm:affiliation>Nordic Bioscience A/S, Herlev, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Nordic Bioscience A/S, Herlev</wicri:regionArea></affiliation></author><author><name sortKey="Hjuler, Sara Toftegaard" sort="Hjuler, Sara Toftegaard" uniqKey="Hjuler S" first="Sara Toftegaard" last="Hjuler">Sara Toftegaard Hjuler</name><affiliation wicri:level="1"><nlm:affiliation>Nordic Bioscience A/S, Herlev, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Nordic Bioscience A/S, Herlev</wicri:regionArea></affiliation></author><author><name sortKey="Furness, Sebastian G" sort="Furness, Sebastian G" uniqKey="Furness S" first="Sebastian G" last="Furness">Sebastian G. Furness</name><affiliation wicri:level="1"><nlm:affiliation>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Sexton, Patrick M" sort="Sexton, Patrick M" uniqKey="Sexton P" first="Patrick M" last="Sexton">Patrick M. Sexton</name><affiliation wicri:level="1"><nlm:affiliation>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Christopoulos, Arthur" sort="Christopoulos, Arthur" uniqKey="Christopoulos A" first="Arthur" last="Christopoulos">Arthur Christopoulos</name><affiliation wicri:level="1"><nlm:affiliation>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Nosjean, Olivier" sort="Nosjean, Olivier" uniqKey="Nosjean O" first="Olivier" last="Nosjean">Olivier Nosjean</name><affiliation wicri:level="1"><nlm:affiliation>Institut de Recherches Servier, Croissy-sur-Seine, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut de Recherches Servier, Croissy-sur-Seine</wicri:regionArea></affiliation></author><author><name sortKey="Karsdal, Morten Asser" sort="Karsdal, Morten Asser" uniqKey="Karsdal M" first="Morten Asser" last="Karsdal">Morten Asser Karsdal</name><affiliation wicri:level="1"><nlm:affiliation>Nordic Bioscience A/S, Herlev, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Nordic Bioscience A/S, Herlev</wicri:regionArea></affiliation></author><author><name sortKey="Henriksen, Kim" sort="Henriksen, Kim" uniqKey="Henriksen K" first="Kim" last="Henriksen">Kim Henriksen</name><affiliation wicri:level="1"><nlm:affiliation>Nordic Bioscience A/S, Herlev, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Nordic Bioscience A/S, Herlev</wicri:regionArea></affiliation></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Arrestins (genetics)</term><term>Arrestins (metabolism)</term><term>Calcitonin (genetics)</term><term>Calcitonin (metabolism)</term><term>Cell Line</term><term>Cyclic AMP (metabolism)</term><term>Gene Expression Regulation</term><term>Humans</term><term>Ligands</term><term>Protein Transport</term><term>Receptors, Calcitonin (genetics)</term><term>Receptors, Calcitonin (metabolism)</term><term>Salmon</term><term>Signal Transduction (genetics)</term><term>Species Specificity</term><term>Time Factors</term><term>Transgenes</term><term>beta-Arrestins</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>AMP cyclique (métabolisme)</term><term>Animaux</term><term>Arrestines (génétique)</term><term>Arrestines (métabolisme)</term><term>Calcitonine (génétique)</term><term>Calcitonine (métabolisme)</term><term>Facteurs temps</term><term>Humains</term><term>Ligands</term><term>Lignée cellulaire</term><term>Récepteurs à la calcitonine (génétique)</term><term>Récepteurs à la calcitonine (métabolisme)</term><term>Régulation de l'expression des gènes</term><term>Saumon</term><term>Spécificité d'espèce</term><term>Transduction du signal (génétique)</term><term>Transgènes</term><term>Transport de protéines</term><term>bêta-Arrestines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Arrestins</term><term>Calcitonin</term><term>Receptors, Calcitonin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Arrestins</term><term>Calcitonin</term><term>Cyclic AMP</term><term>Receptors, Calcitonin</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Signal Transduction</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Arrestines</term><term>Calcitonine</term><term>Récepteurs à la calcitonine</term><term>Transduction du signal</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>AMP cyclique</term><term>Arrestines</term><term>Calcitonine</term><term>Récepteurs à la calcitonine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cell Line</term><term>Gene Expression Regulation</term><term>Humans</term><term>Ligands</term><term>Protein Transport</term><term>Salmon</term><term>Species Specificity</term><term>Time Factors</term><term>Transgenes</term><term>beta-Arrestins</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Facteurs temps</term><term>Humains</term><term>Ligands</term><term>Lignée cellulaire</term><term>Régulation de l'expression des gènes</term><term>Saumon</term><term>Spécificité d'espèce</term><term>Transgènes</term><term>Transport de protéines</term><term>bêta-Arrestines</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Salmon calcitonin (sCT) and human calcitonin (hCT) are pharmacologically distinct. However, the reason for the differences is unclear. Here we analyze the differences between sCT and hCT on the human calcitonin receptor (CT(a)R) with respect to activation of cAMP signaling, β-arrestin recruitment, ligand binding kinetics and internalization. The study was conducted using mammalian cell lines heterologously expressing the human CT(a) receptor. CT(a)R downstream signaling was investigated with dose response profiles for cAMP production and β-arrestin recruitment for sCT and hCT during short term (<2 hours) and prolonged (up to 72 hours) stimulation. CT(a)R kinetics and internalization was investigated with radio-labeled sCT and hCT ligands on cultured cells and isolated membrane preparations from the same cell line. We found that sCT and hCT are equipotent during short-term stimulations with differences manifesting themselves only during long-term stimulation with sCT inducing a prolonged activation up to 72 hours, while hCT loses activity markedly earlier. The prolonged sCT stimulation of both cAMP accumulation and β-arrestin recruitment was attenuated, but not abrogated by acid wash, suggesting a role for sCT activated internalized receptors. We have demonstrated a novel phenomenon, namely that two distinct CT(a)R downstream signaling activation patterns are activated by two related ligands, thereby highlighting qualitatively different signaling responses in vitro that could have implications for sCT use in vivo.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24643196</PMID><DateCreated><Year>2014</Year><Month>03</Month><Day>19</Day></DateCreated><DateCompleted><Year>2014</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.</ArticleTitle><Pagination><MedlinePgn>e92042</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0092042</ELocationID><Abstract><AbstractText>Salmon calcitonin (sCT) and human calcitonin (hCT) are pharmacologically distinct. However, the reason for the differences is unclear. Here we analyze the differences between sCT and hCT on the human calcitonin receptor (CT(a)R) with respect to activation of cAMP signaling, β-arrestin recruitment, ligand binding kinetics and internalization. The study was conducted using mammalian cell lines heterologously expressing the human CT(a) receptor. CT(a)R downstream signaling was investigated with dose response profiles for cAMP production and β-arrestin recruitment for sCT and hCT during short term (<2 hours) and prolonged (up to 72 hours) stimulation. CT(a)R kinetics and internalization was investigated with radio-labeled sCT and hCT ligands on cultured cells and isolated membrane preparations from the same cell line. We found that sCT and hCT are equipotent during short-term stimulations with differences manifesting themselves only during long-term stimulation with sCT inducing a prolonged activation up to 72 hours, while hCT loses activity markedly earlier. The prolonged sCT stimulation of both cAMP accumulation and β-arrestin recruitment was attenuated, but not abrogated by acid wash, suggesting a role for sCT activated internalized receptors. We have demonstrated a novel phenomenon, namely that two distinct CT(a)R downstream signaling activation patterns are activated by two related ligands, thereby highlighting qualitatively different signaling responses in vitro that could have implications for sCT use in vivo.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andreassen</LastName><ForeName>Kim Vietz</ForeName><Initials>KV</Initials><AffiliationInfo><Affiliation>Nordic Bioscience A/S, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjuler</LastName><ForeName>Sara Toftegaard</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Nordic Bioscience A/S, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furness</LastName><ForeName>Sebastian G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sexton</LastName><ForeName>Patrick M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christopoulos</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nosjean</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Institut de Recherches Servier, Croissy-sur-Seine, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karsdal</LastName><ForeName>Morten Asser</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Nordic Bioscience A/S, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriksen</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nordic Bioscience A/S, Herlev, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019390">Arrestins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018003">Receptors, Calcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071557">beta-Arrestins</NameOfSubstance></Chemical><Chemical><RegistryNumber>7SFC6U2VI5</RegistryNumber><NameOfSubstance UI="C028815">salmon calcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-12-9</RegistryNumber><NameOfSubstance UI="D002116">Calcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>E0399OZS9N</RegistryNumber><NameOfSubstance UI="D000242">Cyclic AMP</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Cyclic Nucleotide Protein Phosphor Res. 1983;9(2):129-41</RefSource><PMID Version="1">6315797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomol Screen. 2002 Oct;7(5):451-9</RefSource><PMID Version="1">14599361</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1993 Mar 25;268(9):6415-22</RefSource><PMID Version="1">8454614</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Chem Biol. 2009 Oct;5(10):734-42</RefSource><PMID Version="1">19701185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Endocrinol. 2000 Jul;166(1):213-26</RefSource><PMID Version="1">10856900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 1994 Aug;46(2):246-55</RefSource><PMID Version="1">8078488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Chem Genomics. 2009 May 28;3:22-32</RefSource><PMID Version="1">20161833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1991 Mar 1;251(4997):1078-82</RefSource><PMID Version="1">1847755</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Pharmacol Sci. 2011 Sep;32(9):521-33</RefSource><PMID Version="1">21680031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Endocrinology. 1987 May;120(5):1902-8</RefSource><PMID Version="1">3032571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2115-9</RefSource><PMID Version="1">8134357</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Aug 5;280(31):28610-22</RefSource><PMID Version="1">15929987</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 2009 Jan 23;378(4):804-9</RefSource><PMID Version="1">19070589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Med Chem. 1999 Nov;6(11):1067-93</RefSource><PMID Version="1">10519914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Endocrinology. 1992 Sep;131(3):1497-502</RefSource><PMID Version="1">1324163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Endocrinol (Copenh). 1990 Feb;122(2):255-62</RefSource><PMID Version="1">2156397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2004 Jan 9;279(2):1167-75</RefSource><PMID Version="1">14583624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Obes Metab. 2011 Oct;13(10):911-20</RefSource><PMID Version="1">21615667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Life Sci. 1981 Aug 17;29(7):663-71</RefSource><PMID Version="1">7278506</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pept Sci. 2004 Apr;10(4):179-203</RefSource><PMID Version="1">15119591</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Pharmacol. 2005;52:47-65</RefSource><PMID Version="1">16492540</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone. 2002 May;30(5):655-63</RefSource><PMID Version="1">11996901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Obes Metab. 2011 Dec;13(12):1105-13</RefSource><PMID Version="1">21733060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Mol Biol. 2012 Feb 10;416(1):108-20</RefSource><PMID Version="1">22200484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Opin Biol Ther. 2010 Nov;10(11):1617-29</RefSource><PMID Version="1">20932224</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Biochem Biophys. 2008 May 15;473(2):147-60</RefSource><PMID Version="1">18237538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell Endocrinol. 1988 Jul;58(1):9-15</RefSource><PMID Version="1">2850244</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1981 Dec;78(12):7801-5</RefSource><PMID Version="1">6950419</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Pharmacol. 2012 Sep;167(1):151-63</RefSource><PMID Version="1">22506938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Endocrinol Metab. 1986 Nov;63(5):1080-5</RefSource><PMID Version="1">3760112</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biochem Biophys Res Commun. 1998 Nov 18;252(2):368-72</RefSource><PMID Version="1">9826536</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2004 Jul 23;279(30):31177-82</RefSource><PMID Version="1">15155765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1998 Jul 31;273(31):19809-16</RefSource><PMID Version="1">9677414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Endocrinology. 1984 Jul;115(1):78-83</RefSource><PMID Version="1">6329663</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Pharmacol. 1995 Apr;47(4):798-809</RefSource><PMID Version="1">7723741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pharmacol Rev. 2002 Jun;54(2):233-46</RefSource><PMID Version="1">12037140</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019390" MajorTopicYN="N">Arrestins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002116" MajorTopicYN="N">Calcitonin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000242" MajorTopicYN="N">Cyclic AMP</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018003" MajorTopicYN="N">Receptors, Calcitonin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012474" MajorTopicYN="N">Salmon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019076" MajorTopicYN="N">Transgenes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071557" MajorTopicYN="N">beta-Arrestins</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3958426</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>02</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24643196</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0092042</ArticleId><ArticleId IdType="pii">PONE-D-13-41545</ArticleId><ArticleId IdType="pmc">PMC3958426</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003759 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003759 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24643196
|texte= Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24643196" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |